Cargando…

Pyridine Derivatives as Potential Inhibitors for Coronavirus SARS-CoV-2: A Molecular Docking Study

Coronavirus SARS-CoV-2, a causative agent for the global epidemic disease COVID-19, which has a highest modality rate. Several initiatives have been undertaken to repurpose current antiviral medications and tested the classic pyridine derivatives (PyDev), which have showed substantial therapeutic po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karthick, Kamaraj, Swarnalatha, Kalaiyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076986/ https://www.ncbi.nlm.nih.gov/pubmed/37038549 http://dx.doi.org/10.1177/11779322221146651

Ejemplares similares

Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
por: Li, Daoqun, et al.
Publicado: (2021)

Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors
por: TONG, Jian-Bo, et al.
Publicado: (2021)

Molecular docking analysis of novel quercetin derivatives for combating SARS-CoV-2
por: K. Hussein, Rageh, et al.
Publicado: (2023)

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
por: Yu, Ran, et al.
Publicado: (2020)

Molecular Docking of Cyanine and Squarylium Dyes with NSP15 Endoribonuclease of the SARS-CoV-2 Coronavirus
por: Pronkin, P. G., et al.
Publicado: (2022)

Identification of tuna protein-derived peptides as potent SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
por: Yu, Zhipeng, et al.
Publicado: (2021)

Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
por: Fatriansyah, Jaka Fajar, et al.
Publicado: (2022)

In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
por: Hossain, Rajib, et al.
Publicado: (2021)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
por: Yang, Xinbo, et al.
Publicado: (2022)

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
por: Chidambaram, Sathish Kumar, et al.
Publicado: (2020)

Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2
por: Stefaniu, Amalia, et al.
Publicado: (2020)

Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative
por: K Hussein, Rageh, et al.
Publicado: (2023)

Azaphenantherene derivatives as inhibitor of SARS CoV-2 M(pro): Synthesis, physicochemical, quantum chemical and molecular docking analysis
por: Venkateshan, M., et al.
Publicado: (2020)

Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
por: Han, Tiantian, et al.
Publicado: (2023)

Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
por: Lazniewski, Michal, et al.
Publicado: (2022)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
por: Cheng, Bijun, et al.
Publicado: (2020)

Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
por: Messaoudi, Omar, et al.
Publicado: (2021)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022)

Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis
por: Venkateshan, M., et al.
Publicado: (2020)

Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease
por: Belhassan, Assia, et al.
Publicado: (2020)

SARS-CoV-2 and coagulation disorders in different organs
por: Vinayagam, Sathishkumar, et al.
Publicado: (2020)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

Potential SARS-CoV-2 RdRp inhibitors of cytidine derivatives: Molecular docking, molecular dynamic simulations, ADMET, and POM analyses for the identification of pharmacophore sites
por: M. A. Kawsar, Sarkar, et al.
Publicado: (2022)

Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
por: Suryavanshi, Hemant, et al.
Publicado: (2022)

Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
por: Aljindan, Reem Y., et al.
Publicado: (2021)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

DFT investigations and molecular docking as potent inhibitors of SARS-CoV-2 main protease of 4-phenylpyrimidine
por: Celik, Sibel
Publicado: (2023)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022)

Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies
por: Cherrak, Sabri Ahmed, et al.
Publicado: (2020)

Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis
por: Hakmi, Mohammed, et al.
Publicado: (2020)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
por: Arora, Sumit, et al.
Publicado: (2020)

Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties
por: Khaldan, Ayoub, et al.
Publicado: (2021)

Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
por: Sherif, Yousery E., et al.
Publicado: (2021)

A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
por: Ercan, Selami, et al.
Publicado: (2021)

Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study
por: Vivek-Ananth, R. P., et al.
Publicado: (2021)

Identification of Potential Inhibitors of SARS-CoV-2 Main Protease from Allium roseum L. Molecular Docking Study
por: Benhander, Gazala Mohamed, et al.
Publicado: (2021)

Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study
por: Omar, Alaa Z., et al.
Publicado: (2021)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease
por: Jia, Ze-jun, et al.
Publicado: (2023)

Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2
por: Rampogu, Shailima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tibleh0f13b835invo83bhkmrk